Compare Corteva Inc. Common Stock (CTVA) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corteva Inc. Common Stock vs Immunovant Inc. Common Stock — how do they compare? Corteva Inc. Common Stock trades at $13.4 (market cap $9.17B), while Immunovant Inc. Common Stock trades at $30.56 (market cap $6.25B). The key difference: Corteva Inc. Common Stock is the larger of the two by market cap, and Corteva Inc. Common Stock pays a 5.24% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| CTVA | IMVT | |
|---|---|---|
Market Cap | $9.17B | $6.25B |
Volume | 35,183,471 | 1,755,411 |
Sector | Basic Materials | Health |
52-Week High | $90.51 | $44.96 |
52-Week Low | $11.92 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.68B | $5.35B |
Dividend Yield | 5.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Corteva Inc. Common Stock
Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.
Read more on CTVA →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
